Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janusz Lipiecki

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
ESC Heart Failure|February 23, 2021
Functional outcomes with Carillon device over 1 year in patients with functional mitral regurgitation of Grades 2+ to 4+: results from the REDUCE-FMR trialMuhammad Shahzeb Khan, Tariq Jamal Siddiqi, Javed Butler, et al.
BMC Cardiovascular Disorders|May 15, 2015
Cost-utility analysis of percutaneous mitral valve repair in inoperable patients with functional mitral regurgitation in German settingsOleg Borisenko, Michael Haude, Uta C Hoppe, et al.
European Journal of Heart Failure|July 21, 2021
Treating symptoms and reversing remodelling: clinical and echocardiographic 1-year outcomes with percutaneous mitral annuloplasty for mild to moderate secondary mitral regurgitationKlaus K Witte, David M Kaye, Janusz Lipiecki, et al.
JACC. Cardiovascular Interventions|August 18, 2022
Study Evaluating the Use of RenalGuard to Protect Patients at High Risk of AKISarah Mauler-Wittwer, Horst Sievert, Anna-Maria Ioppolo, et al.
International Journal of Cardiology|April 1, 2014
Bivalirudin in percutaneous coronary intervention: the EUROpean BiValIrudin UtiliSatION in Practice (EUROVISION) RegistryMartial Hamon, Christopher A Nienaber, Stefano Galli, et al.
Open Heart|August 6, 2016
Coronary sinus-based percutaneous annuloplasty as treatment for functional mitral regurgitation: the TITAN II trialJanusz Lipiecki, Tomasz Siminiak, Horst Sievert, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 24, 2018
Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trialJanusz Lipiecki, Philippe Brunel, Marie-Claude Morice, et al.
American Heart Journal|October 17, 2012
Silent cerebral infarcts after cardiac catheterization: a randomized comparison of radial and femoral approachesMartial Hamon, Janusz Lipiecki, Didier Carrié, et al.
The Journal of Invasive Cardiology|April 22, 2022
Clinical Outcomes in Patients Treated With Biodegradable-Polymer Biolimus-Eluting Stents and 6 Months of Dual-Antiplatelet Therapy: The French eBiomatrix 6-Month DAPT RegistryJanusz Lipiecki, Rajiv Rampat, Christophe Piot, et al.
International Journal of Cardiology|July 23, 2022
Mid-term outcome of de novo lesions vs. in stent restenosis treated by intravascular lithotripsy procedures: Insights from the French Shock InitiativeBenjamin Honton, Janusz Lipiecki, Jacques Monségu, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
ESC Heart Failure|February 23, 2021
Functional outcomes with Carillon device over 1 year in patients with functional mitral regurgitation of Grades 2+ to 4+: results from the REDUCE-FMR trialMuhammad Shahzeb Khan, Tariq Jamal Siddiqi, Javed Butler, et al.
BMC Cardiovascular Disorders|May 15, 2015
Cost-utility analysis of percutaneous mitral valve repair in inoperable patients with functional mitral regurgitation in German settingsOleg Borisenko, Michael Haude, Uta C Hoppe, et al.
European Journal of Heart Failure|July 21, 2021
Treating symptoms and reversing remodelling: clinical and echocardiographic 1-year outcomes with percutaneous mitral annuloplasty for mild to moderate secondary mitral regurgitationKlaus K Witte, David M Kaye, Janusz Lipiecki, et al.
JACC. Cardiovascular Interventions|August 18, 2022
Study Evaluating the Use of RenalGuard to Protect Patients at High Risk of AKISarah Mauler-Wittwer, Horst Sievert, Anna-Maria Ioppolo, et al.
International Journal of Cardiology|April 1, 2014
Bivalirudin in percutaneous coronary intervention: the EUROpean BiValIrudin UtiliSatION in Practice (EUROVISION) RegistryMartial Hamon, Christopher A Nienaber, Stefano Galli, et al.
Open Heart|August 6, 2016
Coronary sinus-based percutaneous annuloplasty as treatment for functional mitral regurgitation: the TITAN II trialJanusz Lipiecki, Tomasz Siminiak, Horst Sievert, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 24, 2018
Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trialJanusz Lipiecki, Philippe Brunel, Marie-Claude Morice, et al.
American Heart Journal|October 17, 2012
Silent cerebral infarcts after cardiac catheterization: a randomized comparison of radial and femoral approachesMartial Hamon, Janusz Lipiecki, Didier Carrié, et al.
The Journal of Invasive Cardiology|April 22, 2022
Clinical Outcomes in Patients Treated With Biodegradable-Polymer Biolimus-Eluting Stents and 6 Months of Dual-Antiplatelet Therapy: The French eBiomatrix 6-Month DAPT RegistryJanusz Lipiecki, Rajiv Rampat, Christophe Piot, et al.
International Journal of Cardiology|July 23, 2022
Mid-term outcome of de novo lesions vs. in stent restenosis treated by intravascular lithotripsy procedures: Insights from the French Shock InitiativeBenjamin Honton, Janusz Lipiecki, Jacques Monségu, et al.
Pageof 4